John L. Workman - 20 May 2025 Form 4 Insider Report for CONMED Corp (CNMD)

Reporting relationship: Director
Issuer ticker: CNMD
Reported as of: 20 May 2025
Net transaction value: +$28,663
SEC form: 4
Accepted by SEC: 21 May 2025, 16:25:37 UTC
Prior SEC filing: 23 Apr 2025
Next SEC filing: 12 Nov 2025
Source filing: View source filing
Reporting owner signature: /s/ Thomas Fistek for John L. Workman by Power of Attorney

Key filing fact

John L. Workman filed Form 4 for CONMED Corp (CNMD) on 21 May 2025.

Key facts

This page summarizes John L. Workman's Form 4 filing for CONMED Corp (CNMD).
2 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 21 May 2025, 16:25.

Change

Previous filing in this sequence was filed on 23 Apr 2025.
Current net transaction value: +$28,663.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001302537 Primary reporting owner

Workman John L

Relationship: Director
Address: C/O CONMED CORPORATION, 11311 CONCEPT BOULEVARD, LARGO
Signature: /s/ Thomas Fistek for John L. Workman by Power of Attorney
Signature date: 21 May 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CNMD transaction

Common Stock

Options Exercise

Transaction value: $28,663
Shares: +479
Change %: +2.3%
Price: $59.84
Shares after: 20,891
Date: 20 May 2025
Ownership: Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CNMD transaction Derivative

RSUs (Restricted Stock Units)

Options Exercise

Transaction value: $0
Shares: -479
Change %: -100%
Price: $0.000000
Shares after: 0
Date: 20 May 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 479
Exercise price: $0.000000
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Section 16 status

John L. Workman is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.

Explanation of responses 1 footnote

Footnote F1

Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period with the RSU vesting immediately upon termination of the Director's service.